Kendall David M 4
4 · MANNKIND CORP · Filed Feb 25, 2019
Insider Transaction Report
Form 4
MANNKIND CORPMNKD
Kendall David M
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2019-02-20+37,026→ 44,850 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
- [F2]Restricted stock units shall vest and be delivered on February 20, 2020.